参考文献/References:
[1] ASHINA S, ROBERTSON C E, SRIKIATKHACHORN A, et al. Trigeminal neuralgia[J]. Nature Reviews Disease Primers, 2024, 10(1): 39.
[2] PERGOLIZZI J V J, LEQUANG J A, EL-TALLAWY S N, et al. An update on pharmacotherapy for trigeminal neuralgia[J]. Expert Review of Neurotherapeutics, 2024, 24(8): 773-786.
[3] LI Da, YUAN Chang, ZHAO Bingxiao, et al. lncRNA Kcnq1ot1relieves neuropathic pain through downregulation of Myd88[J]. International Immunopharmacology, 2023, 119: 110218.
[4] LIU Yajing, LIU Fei, LI Yike, et al. LncRNA Anxa10-203 enhances Mc1r mRNA stability to promote neuropathic pain by recruiting DHX30 in the trigeminal ganglion [J]. the Journal of Headache and Pain, 2024, 25(1): 28.
[5] 许牧.LncRNA Gm14461在三叉神经痛中的作用及其机制研究[D].南昌:南昌大学,2021. XU Mu.The role and mechanism of lncRNA Gm14461 in trigeminal neuralgia [D].Nanchang: Nanchang University,2021.
[6] CAI Jun, YAN Yi, ZHANG Daying, et al. Silencing of lncRNA Gm14461 alleviates pain in trigeminal neuralgia through inhibiting astrocyte activation[J]. IUBMB Life, 2020, 72(12): 2663-2671.
[7] LI Lu, LI Tian, QU Xinyu, et al. Stress/cell death pathways,neuroinflammation,and neuropathic pain[J]. Immunological Reviews, 2024, 321(1): 33-51.
[8] MOISSET X. Are CGRP and PACAP involved in the pathophysiology of peripheral neuropathic pain[J]. Revue Neurologique (Paris), 2023, 179(3): 123-124.
[9] XU Mu, YAN Yi, ZHU Mengye, et al. Effects of long non-coding RNA Gm14461 on pain transmission in trigeminal neuralgia[J]. Journal of Inflammation(London), 2020, 17: 1.
[10] 张如月,武彩花,李熳,等.长链非编码RNA调控神经病理性疼痛的研究进展[J].中国疼痛医学杂志, 2021,27(7):490-496. ZHANG Ruyue, WU Caihua, LI Man, et al. Research progress of long non-coding RNA regulating neuropathic pain[J]. Chinese Journal of Pain Medicine,2021, 27(7): 490-496.
[11] WU Shaogen, MARIE LUTZ B, MIAO Xuerong, et al. Dorsal root ganglion transcriptome analysis following peripheral nerve injury in mice [J]. Molecular Pain, 2016, 12:1744806916629048.
[12] WANG Tianyi, LIU Liu, SONG Dongzhe, et al. Emerging roles of lncRNAs in the pathogenesis, diagnosis, and treatment of trigeminal neuralgia[J]. Biochemical Society Transactions, 2022, 50(2): 1013-1023.
[13] MA Xiaohan, ZHU Taomin, KE Jin. Progress in animal models of trigeminal neuralgia[J]. Archives of Oral Biology, 2023, 154: 105765.
[14] ISLAM J, KC E, KIM S, et al. Optogenetic inhibition of glutamatergic neurons in the dysgranular posterior insular cortex modulates trigeminal neuropathic pain in CCI-ION rat[J]. Neuromolecular Medicine, 2023, 25(4): 516-532.
[15] GUO Rong, FANG Yuxin, ZHANG Yuyao, et al. SHED-derived exosomes attenuate trigeminal neuralgia after CCI of the infraorbital nerve in mice via the miR-24-3p/IL-1R1/p-p38 MAPK pathway[J]. Journal of Nanobiotechnology, 2023, 21(1): 458.
[16] KUMARI S, DHAPOLA R, SHARMA P, et al. The impact of cytokines in neuroinflammation-mediated stroke [J]. Cytokine & Growth Factor Reviews, 2024, 78:105-119.
[17] DEMARTINI C, GRECO R, ZANABONI A M, et al. URB937 prevents the development of mechanical allodynia in male rats with trigeminal neuralgia[J]. Pharmaceuticals (Basel,Switzerland), 2023, 16(11): 1626.
[18] DONG B, XU R, LIM M. The pathophysiology of trigeminal neuralgia: a molecular review[J]. Journal of Neurosurgery, 2023, 139(5): 1471-1479.
[19] GINIATULLIN R, NISTRI A. Role of ATP in migraine mechanisms: focus on P2X3 receptors[J]. the Journal of Headache and Pain, 2023, 24(1): 1.
[20] 贾清越,陶怡,闵晓曼,等.中医药调控P2X受体治疗神经病理性疼痛的研究进展[J].中国医药导报, 2024,21(32):59-64. JIA Qingyue, TAO Yi, MIN Xiaoman, et al. Research progress on the regulation of P2X receptors by traditional Chinese medicine in the treatment of neuropathic pain[J]. China Medical Herald, 2024, 21(32): 59-64.
[21] RYAN K, CRIGHTON A. Trigeminal neuralgia and trigeminal neuropathic pain[J]. British Dental Journal, 2024, 236(4): 323-328.
?